The consortium partners comprise a unique network of experts in the fields of tumour biology, biomarker development, clinical sciences and bioinformatics. Members of this consortium are all internationally recognized for their work on CTCs, ctDNA and cfmiRs and have implemented liquid biopsies in clinical research studies.